Cet anticorps anti-DEPDC1B est un anticorps Lapin Polyclonal détectant DEPDC1B dans WB, ELISA et IHC (p). Adapté pour Humain.
N° du produit ABIN6992160
Aperçu rapide pour DEPDC1B anticorps (C-Term) (ABIN6992160)
Antigène
DEPDC1B
(DEP Domain Containing 1B (DEPDC1B))
Reactivité
Humain
Hôte
Lapin
Clonalité
Polyclonal
Conjugué
Cet anticorp DEPDC1B est non-conjugé
Application
Western Blotting (WB), ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
Épitope
C-Term
Specificité
DEPDC1B antibody is human specific. At least two isoforms are known to exist, this antibody will only detect the largest isoform. DEPDC1B antibody is predicted to not cross-react with DEPDC1A.
Purification
DEPDC1B antibody is affinity chromatography purified via peptide column.
Immunogène
DEPDC1B antibody was raised against a 19 amino acid peptide near the carboxy terminus of human DEPDC1B. The immunogen is located within the last 50 amino acids of DEPDC1B.
DEPDC1B
Reactivité: Humain
WB, IF (cc), IF (p)
Hôte: Lapin
Polyclonal
AbBy Fluor® 680
Indications d'application
DEPDC1B antibody can be used for detection of DEPDC1B by Western blot at 1 - 2 μ,g/mL. Antibody can also be used for immunohistochemistry starting at 5 μ,g/mL.
Antibody validated: Western Blot in human samples and Immunohistochemistry in human samples. All other applications and species not yet tested.
Restrictions
For Research Use only
Format
Liquid
Concentration
1 mg/mL
Buffer
DEPDC1B antibody is supplied in PBS containing 0.02 % sodium azide.
Agent conservateur
Sodium azide
Précaution d'utilisation
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Stock
-20 °C,4 °C
Stockage commentaire
DEPDC1B antibody can be stored at 4°C for three months and -20°C, stable for up to one year.
Antigène
DEPDC1B
(DEP Domain Containing 1B (DEPDC1B))
Autre désignation
DEPDC1B
Sujet
The DEP domain-containing 1B (DEPDC1B) protein was initially identified as a radiation response biomarker in human lymphoblastoid cell lines (1). Like the related protein DEPDC1A, expression of DEPDC1B correlates with a poor prognosis in cancer patients (2,3). Studies have shown that DEPDC1B levels are upregulated in non-small cell lung cancer (NSCLC) and have an inverse correlation with patient survival. Ectopic expression of DEPDC1B in NSCLC activated Wnt/B-catenin signaling and enhanced cell migration and invasion while silencing DEPDC1B expression suppressed these traits (2).